• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hevylite 分析验证用于 M 蛋白定量的检测方法。

Analytical validation of the Hevylite assays for M-protein quantification.

机构信息

Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, TheNetherlands.

Deparment of Clinical Chemistry, OLVG, Amsterdam, TheNetherlands.

出版信息

Clin Chem Lab Med. 2018 Jun 27;56(7):1169-1175. doi: 10.1515/cclm-2017-0817.

DOI:10.1515/cclm-2017-0817
PMID:29397379
Abstract

BACKGROUND

The heavy/light chain (HLC) immunoassay quantifies the different heavy chain/light chain combinations of each immunoglobulin (Ig) class. This makes the HLC assay suited to quantify monoclonal immunoglobulins (M-protein) and for monitoring of patients with monoclonal gammopathies. This method is particularly advantageous for those samples in which electrophoretic quantification of the M-protein is not possible.

METHODS

In this study we tested the analytical performance of the HLC assay in 166 routine clinical samples and in 27 samples derived from the Dutch external quality assessment (EQA) for M-protein diagnostics (74 participating laboratories). Analytical accuracy was assessed by verification that the sum of the HLC-pairs equaled total Ig concentration. Sensitivity of the HLC assay was determined in a direct method comparison with immunofixation electrophoresis (IFE).

RESULTS

Comparison of HLC data with routine Ig diagnostics in 27 EQA samples showed very good correlation for both the quantification of polyclonal and monoclonal IgG, IgA and IgM (Pearson correlations [r] were 0.94, 0.99 and 0.99, respectively; slopes were 0.94, 1.07 and 0.98, respectively). The overall concordance between IFE and the HLC ratio was high (93%) with a Cohen κ coefficient of 0.84. Discrepancies between both assays were mainly caused by the higher sensitivity of IFE to detect monoclonality.

CONCLUSIONS

We conclude that the HLC assay is an accurate method to quantify M-proteins that can improve monitoring of M-proteins in the beta fraction that cannot be quantified using electrophoretic techniques.

摘要

背景

重链/轻链(HLC)免疫分析定量测定每个免疫球蛋白(Ig)类别的不同重链/轻链组合。这使得 HLC 分析适合定量单克隆免疫球蛋白(M 蛋白)并监测单克隆丙种球蛋白病患者。该方法特别适用于那些不能通过电泳定量 M 蛋白的样本。

方法

在这项研究中,我们在 166 例常规临床样本和 27 例来自荷兰 M 蛋白诊断外部质量评估(EQA)的样本中测试了 HLC 分析的分析性能(74 个参与实验室)。通过验证 HLC 对的总和等于总 Ig 浓度,评估分析准确性。通过与免疫固定电泳(IFE)的直接方法比较,确定 HLC 分析的灵敏度。

结果

在 27 份 EQA 样本中,将 HLC 数据与常规 Ig 诊断进行比较,均显示出很好的相关性,无论是对多克隆和单克隆 IgG、IgA 和 IgM 的定量(Pearson 相关系数[r]分别为 0.94、0.99 和 0.99;斜率分别为 0.94、1.07 和 0.98)。IFE 和 HLC 比值之间的总体一致性很高(93%),Cohen κ 系数为 0.84。两种检测方法之间的差异主要是由于 IFE 检测单克隆性的灵敏度更高。

结论

我们得出结论,HLC 分析是一种定量 M 蛋白的准确方法,可以改善对无法通过电泳技术定量的β馏分中的 M 蛋白的监测。

相似文献

1
Analytical validation of the Hevylite assays for M-protein quantification.Hevylite 分析验证用于 M 蛋白定量的检测方法。
Clin Chem Lab Med. 2018 Jun 27;56(7):1169-1175. doi: 10.1515/cclm-2017-0817.
2
Analytical performance and diagnostic potential of immunoassays determining intact immunoglobulin kappa/lambda ratios in monoclonal gammopathies.免疫测定法在单克隆丙种球蛋白病中测定完整免疫球蛋白κ/λ比值的分析性能及诊断潜力
Clin Lab. 2014;60(9):1491-500. doi: 10.7754/clin.lab.2013.131010.
3
[Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].[多发性骨髓瘤诊断时免疫球蛋白重链/轻链对(Hevylite)与血清蛋白凝胶电泳及散射比浊检测结果的关系分析]
Cas Lek Cesk. 2015;154(6):292-302.
4
Heavy/light chain assay in the monitoring of multiple myeloma.重链/轻链检测在多发性骨髓瘤监测中的应用。
Pathology. 2019 Aug;51(5):507-511. doi: 10.1016/j.pathol.2019.04.002. Epub 2019 Jun 25.
5
The serum heavy/light chain immunoassay: A valuable tool for sensitive paraprotein assessment, risk, and disease monitoring in monoclonal gammopathies.血清重/轻链免疫分析:在单克隆丙种球蛋白病中,用于敏感副蛋白评估、风险和疾病监测的有价值工具。
Eur J Haematol. 2017 Nov;99(5):449-458. doi: 10.1111/ejh.12958. Epub 2017 Oct 5.
6
Immunoglobulin heavy chain/light chain pairs (HLC, Hevylite™) assays for diagnosing and monitoring monoclonal gammopathies.免疫球蛋白重链/轻链配对(HLC,Hevylite™)检测在单克隆丙种球蛋白病的诊断和监测中的应用。
Adv Clin Exp Med. 2014 Jan-Feb;23(1):127-33. doi: 10.17219/acem/37036.
7
Monitoring IgA multiple myeloma: immunoglobulin heavy/light chain assays.监测 IgA 多发性骨髓瘤:免疫球蛋白重/轻链检测。
Clin Chem. 2015 Feb;61(2):360-7. doi: 10.1373/clinchem.2014.231985. Epub 2014 Dec 1.
8
Abnormal Heavy/Light Chain Ratio and Matched Pair Suppression Increase Residual Disease Detection Sensitivity in Patients With Multiple Myeloma With Deep Responses.异常重链/轻链比值和配对抑制增加了深度缓解多发性骨髓瘤患者的残留疾病检测灵敏度。
Clin Lymphoma Myeloma Leuk. 2018 Apr;18(4):293-296. doi: 10.1016/j.clml.2018.01.008. Epub 2018 Feb 19.
9
Relationship of differences in immunoglobulin heavy/light chain pairs (Hevylite), selected laboratory parameters and stratification systems in different immunochemical types of multiple myeloma.不同免疫化学类型多发性骨髓瘤中免疫球蛋白重/轻链对(Hevylite)差异、选定实验室参数与分层系统之间的关系
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Mar;160(1):84-93. doi: 10.5507/bp.2015.032. Epub 2015 Aug 4.
10
IgMκ-IgMλ pair quantitation in the clinical laboratory practice.临床实验室实践中IgMκ-IgMλ对的定量分析
Clin Biochem. 2018 Jan;51:56-60. doi: 10.1016/j.clinbiochem.2016.11.007. Epub 2016 Nov 10.

引用本文的文献

1
Immunoglobulin heavy/light chain assay in the diagnosis, monitoring and follow-up of renal AL amyloidosis patients at different disease stages.免疫球蛋白重链/轻链检测在不同疾病阶段肾AL淀粉样变性患者诊断、监测及随访中的应用
Ann Hematol. 2025 Apr;104(4):2287-2295. doi: 10.1007/s00277-025-06345-7. Epub 2025 Apr 9.
2
Response-Adapted Therapy for Newly Diagnosed Multiple Myeloma.新诊断多发性骨髓瘤的应答适应性治疗。
Curr Hematol Malig Rep. 2023 Oct;18(5):190-200. doi: 10.1007/s11899-023-00704-9. Epub 2023 Jul 4.
3
Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma.
单克隆丙种球蛋白病和多发性骨髓瘤管理中重链/轻链(HLC)检测的实验室及临床背景
J Pers Med. 2023 Apr 27;13(5):743. doi: 10.3390/jpm13050743.
4
The Current Role of the Heavy/Light Chain Assay in the Diagnosis, Prognosis and Monitoring of Multiple Myeloma: An Evidence-Based Approach.重链/轻链分析在多发性骨髓瘤诊断、预后及监测中的当前作用:基于证据的方法
Diagnostics (Basel). 2021 Oct 30;11(11):2020. doi: 10.3390/diagnostics11112020.